At the present time, the diagnosis of CS is based on suggestive clinical features and pathogenic variants in SLC9A6 identified by molecular genetic testing, but sometimes diagnosis based on mutation analysis can be inconclusive in patients suspected of CS because a number of genetic variants are of unknown significance according to the American College of Medical Genetics and Genomics guideline. The gene discussed is SLC9A6; the disease is Cowden syndrome 1.